To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Medley soldiers on with merger amid shareholder backlash
MCC has faced scrutiny from shareholders over plans to merge with MDLY, despite an independent committee finding it to be the best option for the portfolio's performance.
